Evidence map›Paper›PMID 42147893›Full record

ArticleQuantitative imaging in medicine and surgery2026

The clinicopathological and imaging parameters contributing to the similarity network fusion subtypes and prognosis of hormone receptor-positive HER2-negative breast cancer: an exploratory study.

Ruoqing Hou, Jiawei Li, Xueqin Meng, Meidi Zhang, Zhanping You, Kai Zhang, Jiawei Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ruoqing Hou *Department of Medical Ultrasound, Fudan University Shanghai Cancer Center, Shanghai, China.
Jiawei Li *Department of Medical Ultrasound, Fudan University Shanghai Cancer Center, Shanghai, China.
Xueqin Meng *Department of Medical Ultrasound, Fudan University Shanghai Cancer Center, Shanghai, China.
Meidi ZhangDepartment of Medical Ultrasound, Fudan University Shanghai Cancer Center, Shanghai, China.
Zhanping YouDepartment of Medical Ultrasound, Fudan University Shanghai Cancer Center, Shanghai, China.
Kai ZhangDepartment of Medical Ultrasound, Fudan University Shanghai Cancer Center, Shanghai, China.
Jiawei LiDepartment of Medical Ultrasound, Fudan University Shanghai Cancer Center, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hormone receptor-positive (HR Methods: This retrospective analysis comprehensively summarized the clinicopathological and imaging profiles of 347 patients (mean age, 53±11 years) with pathologically confirmed HR Results: Among all clinical indicators, the histological grade, Ki-67 index, estrogen receptor (ER) grade, and BI-RADS grade of MG exhibited statistically significant variations across the four subtypes exert a notable effect on the SNF subtypes of the HR Conclusions: Both clinical and pathological indicators, alongside imaging BI-RADS classification, played a pivotal role in discriminating the SNF subtype of HR

Indexed as

breast cancerclinicopathologicalimagingprognosisSimilarity network fusion subtype (SNF subtype)

Identifiers

PMID42147893
PMCPMC13178362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.